ArticleJournal of hematology & oncology2016

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.

Jessica T Leonard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.